Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tetromycin A (CAS 180027-83-2)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Application:
Tetromycin A is an antibiotic against antibiotic resistant and susceptible gram-positive bacteria including MRSA
CAS Number:
180027-83-2
Purity:
>99%
Molecular Weight:
576.77
Molecular Formula:
C36H48O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Tetromycin A, identified by CAS number 180027-83-2, is a complex polyketide-derived compound produced by various species of the actinomycete genus Streptomyces. This compound belongs to the tetronate class of antibiotics, characterized by its unique tetronic acid core linked to a macrocyclic lactone ring. The mechanism of action of Tetromycin A involves the inhibition of bacterial type II topoisomerases, such as DNA gyrase and topoisomerase IV. These enzymes are critical for DNA replication, transcription, and chromosomal segregation, as they manage the topology of DNA during these processes. By binding to and stabilizing the enzyme-DNA complex, Tetromycin A effectively prevents the re-ligation step of the DNA cleavage-relegation cycle, leading to disruptions in DNA processes and ultimately, bacterial cell death. In research, Tetromycin A has been utilized as a valuable tool to study bacterial DNA topology and the enzymes associated with it. Its specific inhibition of type II topoisomerases has allowed researchers to dissect the roles of these enzymes in bacterial viability and develop a deeper understanding of their mechanism of action. Furthermore, the study of Tetromycin A contributes to the exploration of potential novel targets for antibiotic action, particularly in the context of rising antibiotic resistance. This research is pivotal for advancing the development of alternative strategies to combat bacterial infections effectively.


Tetromycin A (CAS 180027-83-2) References

  1. Effect on tumor cells of blocking survival response to glucose deprivation.  |  Park, HR., et al. 2004. J Natl Cancer Inst. 96: 1300-10. PMID: 15339968
  2. Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers.  |  Nakajima, H., et al. 2007. Biochem Biophys Res Commun. 356: 260-5. PMID: 17350598
  3. Deglycosylation as a mechanism of inducible antibiotic resistance revealed using a global relational tree for one-component regulators.  |  Cuthbertson, L., et al. 2013. Chem Biol. 20: 232-40. PMID: 23438752

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Tetromycin A, 500 µg

sc-202359
500 µg
$280.00